Donald Paul Reitberg
Pharmacy in Bedminster, NJ
License number
Utah 143677-8911
Issued Date
Jan 1, 1911
Expiration Date
Sep 30, 2017
Category
Pharmacy
Type
Pharmacist Controlled Substance
Address
Address
Bedminster, NJ
Professional information
Method And Kit For Treating Illnesses
US Patent:
6579888, Jun 17, 2003
Filed:
Mar 30, 2001
Appl. No.:
09/823329
Inventors:
Donald P. Reitberg - Bedminster NJ
Assignee:
Opt-e-scrip, Inc. - Morristown NJ
International Classification:
A01N 4340
US Classification:
514317
Abstract:
Methods and kits for determining appropriate treatment for illnesses in humans or animals are disclosed. The method includes: providing a test kit containing a random arrangement of drug(s) and placebo(s) and/or alternative treatment(s) along with a questionnaire or other instrument designed to elicit data concerning the safety, efficacy and desirability of a treatment; administering the drug(s) and placebo(s) and/or alternative treatments to each member of the pool in a random, double blind fashion and following up on patient outcomes as appropriate post-study; assembling a database from the completed pool questionnaires and revealing the random schedule to uncover drug and placebo treatment periods; providing the same kit to a patient in need of the same treatment and comparing the results obtained from the single patient trial with those obtained from the pool to determine an optimal treatment for the patient with the drug; and administering a treatment consistent with the optimal treatment.
Method And Kit For Treating Illnesses
US Patent:
6242463, Jun 5, 2001
Filed:
Oct 31, 1994
Appl. No.:
8/331913
Inventors:
Donald P. Reitberg - Bedminster NJ
Assignee:
Opt-e-scrip, Inc. - Morristown NJ
International Classification:
A01N 4340, A01K 3302, A01K 33135
US Classification:
514317
Abstract:
Methods and kits for determining appropriate treatment for illnesses in humans or animals are disclosed. The method includes:
providing a test kit containing a random arrangement of drug(s) and placebo(s) and/or alternative treatment(s) along with a questionnaire or other instrument designed to elicit data concerning the safety, efficacy and desirability of a treatment;
administering the drug(s) and placebo(s) and/or alternative treatments to each member of the pool in a random, double blind fashion and following up on patient outcomes as appropriate post-study;
assembling a database from the completed pool questionnaires and revealing the random schedule to uncover drug and placebo treatment periods;
providing the same kit to a patient in need of the same treatment and comparing the results obtained from the single patient trial with those obtained from the pool to determine an optimal treatment for the patient with the drug; and
administering a treatment consistent with the optimal treatment.
Method And System For Consumer-Specific Communication Based On Cultural Normalization Techniques
US Patent:
2011020, Aug 25, 2011
Filed:
Feb 23, 2011
Appl. No.:
13/033033
Inventors:
Eve Del Rio - Bridgewater NJ, US
Donald P. Reitberg - Bedminster NJ, US
Juan G. Espinosa - Weehawken NJ, US
Fernando Hernandez - Issaquah WA, US
Donald P. Reitberg - Bedminster NJ, US
Juan G. Espinosa - Weehawken NJ, US
Fernando Hernandez - Issaquah WA, US
Assignee:
FARMACIA ELECTRONICA, INC. - Weehawken NJ
International Classification:
G06F 3/01, G06F 15/16
US Classification:
715733
Abstract:
A method and system for providing consumer-specific communication based on cultural-normalization techniques. The method includes obtaining information about the consumer using an interactive interface, receiving an identification of a consumer-selected language and an output format selection, providing plain-language output information in the consumer-selected language and output format, presenting questions, by a query/interrogation unit, regarding the plain-language output information, acquiring responses to the presented questions, and ascertaining an understanding of the plain-language output information based on the acquired responses. The system includes a controller, an interactive interface unit, a format selection unit, a language selection unit providing content in a user-selected language, a query/interrogation unit, and a response evaluation unit analyzing responses to determine a user's literacy level. The response evaluation unit configured to mine, analyze, and/or parse contents of a database containing user responses to the queries.
Single-Patient Drug Trials Used With Accumulated Database: Flowchart
US Patent:
2002019, Dec 19, 2002
Filed:
Jun 1, 2001
Appl. No.:
09/872815
Inventors:
Donald Reitberg - Bedminster NJ, US
International Classification:
A61K049/00, G06F017/60
US Classification:
424/009100, 705/003000
Abstract:
A method of evaluating and/or optimizing clinical outcomes and providing rational pharmacotherapy in an individual or animal requiring chronic drug therapy is provided.
Single-Patient Drug Trials Used With Accumulated Database: Risk Of Habituation
US Patent:
2002003, Mar 14, 2002
Filed:
Jun 1, 2001
Appl. No.:
09/872506
Inventors:
Donald Reitberg - Bedminster NJ, US
International Classification:
G06F017/60, G06F007/00, G06F017/00
US Classification:
705/002000, 707/104100
Abstract:
A method of evaluating and/or optimizing clinical outcomes and providing rational pharmacotherapy in an individual or animal requiring chronic drug therapy is provided.
Methods To Abate The Use Of Tobacco By Humans
US Patent:
6224897, May 1, 2001
Filed:
Sep 29, 1998
Appl. No.:
9/162754
Inventors:
Donald Paul Reitberg - Bedminster NJ
Assignee:
Novartis Consumer Health S.A. - Nyon
International Classification:
A61K 972
US Classification:
424443
Abstract:
The present invention is directed to patient-controlled, flexible-dosing methods of treatment utilizing transdermal nicotine patch devices, optionally with other nicotine delivery systems, to abate the use of tobacco in humans.